Dublin, Aug. 29, 2024 (GLOBE NEWSWIRE) -- The "Therapeutic Vaccines - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Therapeutic Vaccines is estimated at US$39.9 Billion in 2023 and is projected to reach US$117.1 Billion by 2030, growing at a CAGR of 16.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. 
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Autoimmune Disease Vaccines segment, which is expected to reach US$62.8 Billion by 2030 with a CAGR of a 17.2%. The Neurological Disease Vaccines segment is also set to grow at 17.5% CAGR over the next 7 years.
- Regional Analysis: Gain insights into the U.S. market, estimated at $10.6 Billion in 2023, and China, forecasted to grow at an impressive 21.9% CAGR to reach $29.2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Agenus, Inc., Bavarian Nordic A/S, CEL-SCI Corporation, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 182 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $39.9 Billion |
| Forecasted Market Value (USD) by 2030 | $117.1 Billion |
| Compound Annual Growth Rate | 16.6% |
| Regions Covered | Global |
Key Topics Covered:
MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Therapeutic Vaccines - Global Key Competitors Percentage Market Share in 2024 (E)
- Global Economic Update
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
FOCUS ON SELECT PLAYERS(Total 13 Featured)
- Agenus, Inc.
- Bavarian Nordic A/S
- CEL-SCI Corporation
- Dendreon Corporation
- GlaxoSmithKline PLC
- Novartis International AG
- Oncothyreon, Inc.
- TVAX Biomedical Inc.
- Vical, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/wuex2
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
